Fig. 1From: Long-term treatment of evocalcet in hemodialysis patients with secondary hyperparathyroidism: a five-year prospective cohort study in 147 Japanese patientsEvocalcet dosage after switching from cinacalcet. The median evocalcet dose was 1 mg/day at 0.5 years and was maintained at 2 mg/day from 1 to 5 years after the switch. The number of patients receiving evocalcet at 1, 3, and 5 years is presented in Table 2. × mean valuesBack to article page